[Use of disease-modifying therapies in spinal muscular atrophy 5q in Mexico]. [PDF]
Meza-Cano ME, Molina-Castillo C.
europepmc +1 more source
Type-1 spinal muscular atrophy cohort before and after disease-modifying therapies. [PDF]
Alves BKAMF +3 more
europepmc +1 more source
Reabilitação em cães com atrofia muscular induzida
Pós-graduação em Cirurgia Veterinária ...
openaire +1 more source
Why should a 5q spinal muscular atrophy neonatal screening program be started? [PDF]
Becker MM +5 more
europepmc +1 more source
X-linked spinal and bulbar muscular atrophy (Kennedy's disease): the first case described in the Brazilian Amazon. [PDF]
Alves CN +5 more
europepmc +1 more source
The effects of disease-modifying therapies in SMA-5q type 1 and the importance of early diagnosis of the disease. [PDF]
Zanoteli E.
europepmc +1 more source
Quality of life in patients with spinal muscular atrophy in Brazil: patient self-assessment and carer perception. [PDF]
Coelho M +3 more
europepmc +1 more source
Consensus from the Brazilian Academy of Neurology for the diagnosis, genetic counseling, and use of disease-modifying therapies in 5q spinal muscular atrophy. [PDF]
Zanoteli E +15 more
europepmc +1 more source
[Clinical spectrum, neuroimaging and therapeutic response to neurological syndromes associated with anti-GAD65]. [PDF]
Hernández-Salomón LF +5 more
europepmc +1 more source

